Elevance Health
1,555 hedge funds and large institutions have $71B invested in Elevance Health in 2025 Q4 according to their latest regulatory filings, with 221 funds opening new positions, 501 increasing their positions, 612 reducing their positions, and 152 closing their positions.
53% more call options, than puts
Call options by funds: $814M | Put options by funds: $530M
45% more first-time investments, than exits
New positions opened: 221 | Existing positions closed: 152
12% more capital invested
Capital invested by funds: $63.3B → $71B (+$7.67B)
3.98% more ownership
Funds ownership: 87.02% → 91% (+4%)
3% more funds holding
Funds holding: 1,511 → 1,555 (+44)
3% less funds holding in top 10
Funds holding in top 10: 32 → 31 (-1)
18% less repeat investments, than reductions
Existing positions increased: 501 | Existing positions reduced: 612
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$564M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$543M |
| 3 |
Harris Associates
Chicago,
Illinois
|
+$542M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$441M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$421M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$462M |
| 2 |
BWA
Brave Warrior Advisors
New York
|
-$197M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$131M |
| 4 |
MGP
M&G plc
London,
United Kingdom
|
-$130M |
| 5 |
Caisse de Depot et Placement du Quebec (CDPQ)
Montreal,
Quebec, Canada
|
-$120M |
ELV Hedge Fund Activity: Q4 2025 in Review
1,555 of the 8,261 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q4 2025, worth a combined $71B — up 12% from $63.3B a quarter earlier.
Buyers outnumbered sellers: 221 funds opened new ELV positions and 152 closed out — a net gain of 69 holders — while 501 added to existing stakes and 612 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $564M. The largest seller was Capital International Investors, cutting an estimated $462M.
- 1,555 institutional investors held Elevance Health (ELV) as of Q4 2025, up from 1,511 in Q3 2025.
- Funds reported $71B of Elevance Health stock for Q4 2025, up 12% quarter-over-quarter.
- 221 funds opened new Elevance Health positions in Q4 2025 and 152 closed out, a net change of +69 holders.
- The largest Elevance Health buyer in Q4 2025 was Wellington Management Group, an estimated $564M added.
- The largest Elevance Health seller in Q4 2025 was Capital International Investors, an estimated $462M sold.
Based on aggregated 13F filings for Q4 2025.